GILD

Q: What is the price of Gilead Sciences (GILD) today?

The price of Gilead Sciences (GILD) today is $ 125.27, with return of 43.45% compared to the last year. The price of Gilead Sciences (GILD) started the year trading around $ 92.37 and today it is at $ 125.27. Follow the real-time price chart, the historical price of Gilead Sciences (GILD) and international markets.

Q: When does Gilead Sciences (GILD) pay dividends?

Gilead Sciences (GILD) distributed dividends in the last year,in the months of March, June and September totaling $ 2.37. The Dividend Yield for the last 12 months is 2.48%.

Q: Is Gilead Sciences (GILD) worth it?

Currently, Gilead Sciences (GILD) is priced at $ 125.27, with a P/E of 19.41%, representando um desvio de 5,936% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 43.45 in its price and distributed $ 2.37 in dividends, resulting in a Dividend Yield of 2.48%. The total shareholder return was 43.45%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Gilead Sciences (GILD) stock?

Investing in stocks of Gilead Sciences (GILD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Gilead Sciences (GILD) yield today?

The yield of Gilead Sciences (GILD) was 4.23% in the last month, 43.45% in the last year and 155.88% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 3.14 in dividends, a Dividend Yield of 2.48%.If you wanted to buy 100 stocks of Gilead Sciences (GILD) today, the total investment would be $ 12,527.00, based on the current price of $ 125.27.If past performance were to repeat, the return on your investment would be:In 1 year: $ 17,969.98In 5 years: $ 32,054.09In 10 years: $ 21,210.72It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Gilead Sciences Inc.

Price

$ 125.27

return (12m)

43.45%

p/e

19.41

p/bv

7.34

DIVIDEND YIELD

2.48%

price GILD

BVMF

GILD

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of GILD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.23%

3 months

11.42%

1 year

43.45%

2 years

80.54%

5 years

155.88%

10 years

69.32%

Fundamentals GILD

review the fundamentals of Gilead Sciences shares

P/E

19.41

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

5.41

Sector: -3.36 Industry: -3.36

P/BV

7.34

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

2.48%

Sector: - Industry: -

ROA

13.86%

Sector: -62.78% Industry: -62.78%

ROE

37.80%

Sector: -68.26% Industry: -68.26%

ROIC

23.86%

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

27.88%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

78.71%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

38.34%

Sector: -41.58% Industry: -41.58%

P/EBITDA

13.57

Sector: -3.48 Industry: -3.48

P/EBIT

14.43

Sector: -3.60 Industry: -3.60

P/ASSET

2.69

Sector: 1.42 Industry: 1.42

BVPS

17.26

Sector: 1.79 Industry: 1.79

EPS

6.52

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.37

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

3.33%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

131.11%

Sector: - Industry: -

FAIR VALUE OF Gilead Sciences ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 125.27

Fair Value

$ 0.00

Upside Return potential.

-59.83%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GILD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
VRTX	29.73	6.31	21.22%	0.00%	$ 109.25 B	31.35%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%
HRMY	10.72	2.38	22.24%	0.00%	$ 1.99 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GILD Historical Dividends

current DY: 2.48%

5-year average DY: 4.27%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	12/15/2025	12/30/2025	0,79000000
Dividend	09/15/2025	09/29/2025	0,79000000
Dividend	06/13/2025	06/27/2025	0,79000000
Dividend	03/14/2025	03/28/2025	0,79000000
Dividend	12/13/2024	12/30/2024	0,77000000
Dividend	09/13/2024	09/27/2024	0,77000000
Dividend	06/14/2024	06/27/2024	0,77000000
Dividend	03/15/2024	03/28/2024	0,77000000
Dividend	12/15/2023	12/28/2023	0,75000000
Dividend	09/15/2023	09/28/2023	0,75000000
Dividend	06/15/2023	06/29/2023	0,75000000
Dividend	03/15/2023	03/30/2023	0,75000000
Dividend	12/15/2022	12/29/2022	0,73000000
Dividend	09/15/2022	09/29/2022	0,73000000
Dividend	06/15/2022	06/29/2022	0,73000000
Dividend	03/15/2022	03/30/2022	0,73000000
Dividend	12/15/2021	12/30/2021	0,71000000
Dividend	09/15/2021	09/29/2021	0,71000000
Dividend	06/15/2021	06/29/2021	0,71000000
Dividend	03/15/2021	03/30/2021	0,71000000
Dividend	12/15/2020	12/30/2020	0,68000000
Dividend	09/15/2020	09/29/2020	0,68000000
Dividend	06/12/2020	06/29/2020	0,68000000
Dividend	03/13/2020	03/30/2020	0,68000000
Dividend	12/13/2019	12/30/2019	0,63000000
Dividend	09/13/2019	09/27/2019	0,63000000
Dividend	06/14/2019	06/27/2019	0,63000000
Dividend	03/15/2019	03/28/2019	0,63000000
Dividend	12/14/2018	12/28/2018	0,57000000
Dividend	09/14/2018	09/27/2018	0,57000000
Dividend	06/15/2018	06/28/2018	0,57000000
Dividend	03/16/2018	03/29/2018	0,57000000
Dividend	12/15/2017	12/28/2017	0,52000000
Dividend	09/15/2017	09/28/2017	0,52000000
Dividend	06/16/2017	06/29/2017	0,52000000
Dividend	03/16/2017	03/30/2017	0,52000000
Dividend	12/15/2016	12/29/2016	0,47000000
Dividend	09/16/2016	09/29/2016	0,47000000
Dividend	06/16/2016	06/29/2016	0,47000000
Dividend	03/16/2016	03/30/2016	0,43000000
Dividend	12/16/2015	12/30/2015	0,43000000
Dividend	09/16/2015	09/29/2015	0,43000000
Dividend	06/16/2015	06/29/2015	0,43000000

ABOUT THE COMPANY Gilead Sciences

Gilead Sciences Inc.

Average user rating I10

4.0 (64 people)

United States

38 years

Founded: 1987

1992

Time since IPO - 33 years

13.600

Employees

The Company Gilead Sciences Inc. (United States), is listed on Nasdaq with a market cap of $ 157.41 Billions, having an equity of $ 21.46 Billions.

With a total of 13.600 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 29.09 Billions, which generated a profit in the amount of $ 8.11 Billions.

As for its main indicators, the Company has a P/E ratio of 19.41, a P/BV ratio of 7.34 and in the last 12 months the dividend yield of GILD was at 2.48%.

The Company is traded internationally through the ticker GILD.

Market cap

$ 157.41 Billions

Equity

$ 21.46 Billions

US$ 21,456,000,000.00

Assets

$ 58.53 Billions

US$ 58,533,000,000.00

Total Shares Outstanding

1.24 Billion

1,243,000,000

Average Daily Trading Volume

$ 7.49 Millions

US$ 7,488,972.00

Sector

Health Care

Industry

Biotechnology

GILD

GILD revenue and profits

Financial Results GILD

DRAG THE FRAME TO SEE MORE DATA

GILD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 870.21 41,86% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 211.20 76,36% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.05 37,46% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.40 3,83% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.22 6,38% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 229.51 34,15% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 91.52 40,77% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 870.21 41,86% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 211.20 76,36% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.05 37,46% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.40 3,83% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.22 6,38% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 229.51 34,15% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 91.52 40,77% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

Frequently Asked Questions

What is the price of Gilead Sciences (GILD) today?

The price of Gilead Sciences (GILD) today is $ 125.27, with return of 43.45% compared to the last year. The price of Gilead Sciences (GILD) started the year trading around $ 92.37 and today it is at $ 125.27. Follow the real-time price chart, the historical price of Gilead Sciences (GILD) and international markets.

When does Gilead Sciences (GILD) pay dividends?

Gilead Sciences (GILD) distributed dividends in the last year,in the months of March, June and September totaling $ 2.37. The Dividend Yield for the last 12 months is 2.48%.

Is Gilead Sciences (GILD) worth it?

Currently, Gilead Sciences (GILD) is priced at $ 125.27, with a P/E of 19.41%, representando um desvio de 5,936% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 43.45 in its price and distributed $ 2.37 in dividends, resulting in a Dividend Yield of 2.48%. The total shareholder return was 43.45%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Gilead Sciences (GILD) stock?

Investing in stocks of Gilead Sciences (GILD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Gilead Sciences (GILD) yield today?

The yield of Gilead Sciences (GILD) was 4.23% in the last month, 43.45% in the last year and 155.88% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 3.14 in dividends, a Dividend Yield of 2.48%.

If you wanted to buy 100 stocks of Gilead Sciences (GILD) today, the total investment would be $ 12,527.00, based on the current price of $ 125.27.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 17,969.98
In 5 years: $ 32,054.09
In 10 years: $ 21,210.72

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GILD

Gilead Sciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of GILD

review the fundamentals of Gilead Sciences shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 2.48%

5-year average DY: 4.27%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Gilead Sciences

Gilead Sciences Inc.

United States

38 years

1992

13.600

PROFIT X PRICE GILD

Financial Results GILD

GILD cash flow

asset growth - GILD

GILD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions